• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗氧化型低密度脂蛋白自身抗体与颈动脉粥样硬化进展

Autoantibody against oxidised LDL and progression of carotid atherosclerosis.

作者信息

Salonen J T, Ylä-Herttuala S, Yamamoto R, Butler S, Korpela H, Salonen R, Nyyssönen K, Palinski W, Witztum J L

机构信息

Research Institute of Public Health, University of Kuopio, Finland.

出版信息

Lancet. 1992 Apr 11;339(8798):883-7. doi: 10.1016/0140-6736(92)90926-t.

DOI:10.1016/0140-6736(92)90926-t
PMID:1348295
Abstract

Oxidative modification of LDL renders it immunogenic and autoantibodies to epitopes of oxidised LDL, such as malondialdehyde (MDA)-lysine, are found in serum and recognise material in atheromatous tissue. However, there has been no prospective study to assess the importance of oxidised LDL among patients with vascular disease. We compared the titre of autoantibodies to MDA-modified LDL and native LDL in baseline serum samples of 30 eastern Finnish men with accelerated two-year progression of carotid atherosclerosis and 30 age-matched controls without progression. Neither group had specific antibody binding to native LDL. A titre was defined as a ratio of antibody binding to MDA-LDL/binding to native LDL. Cases had a significantly higher titre to MDA-LDL (2.67 vs 2.06, p = 0.003). Cases also had a greater proportion of smokers (37% vs 3%), higher LDL cholesterol (4.2 mmol/l vs 3.6 mmol/l), and higher serum copper concentration (1.14 mg/l vs 1.04 mg/l). Even after adjusting for these variables and the severity of baseline atherosclerosis, the difference in antibody titre remained significant in a multifactorial logistic model (p = 0.031). Thus, the titre of autoantibodies to MDA-LDL was an independent predictor of the progression of carotid atherosclerosis in these Finnish men. Our data provide further support for a role of oxidatively modified LDL in atherogenesis.

摘要

低密度脂蛋白(LDL)的氧化修饰使其具有免疫原性,血清中可发现针对氧化型LDL表位的自身抗体,如丙二醛(MDA)-赖氨酸抗体,且这些抗体可识别动脉粥样硬化组织中的物质。然而,尚无前瞻性研究评估氧化型LDL在血管疾病患者中的重要性。我们比较了30名芬兰东部男性颈动脉粥样硬化加速进展患者与30名年龄匹配的无进展对照者的基线血清样本中,针对MDA修饰的LDL和天然LDL的自身抗体滴度。两组均无针对天然LDL的特异性抗体结合。滴度定义为抗体与MDA-LDL结合/与天然LDL结合的比值。病例组针对MDA-LDL的滴度显著更高(2.67对2.06,p = 0.003)。病例组吸烟者比例也更高(37%对3%),低密度脂蛋白胆固醇水平更高(4.2 mmol/l对3.6 mmol/l),血清铜浓度更高(1.14 mg/l对1.04 mg/l)。即使在对这些变量以及基线动脉粥样硬化的严重程度进行校正后,在多因素逻辑模型中抗体滴度的差异仍具有显著性(p = 0.031)。因此,针对MDA-LDL的自身抗体滴度是这些芬兰男性颈动脉粥样硬化进展的独立预测因子。我们的数据进一步支持了氧化修饰的LDL在动脉粥样硬化发生中的作用。

相似文献

1
Autoantibody against oxidised LDL and progression of carotid atherosclerosis.抗氧化型低密度脂蛋白自身抗体与颈动脉粥样硬化进展
Lancet. 1992 Apr 11;339(8798):883-7. doi: 10.1016/0140-6736(92)90926-t.
2
Presence of autoantibodies against oxidatively modified low-density lipoprotein in essential hypertension: a biochemical signature of an enhanced in vivo low-density lipoprotein oxidation.原发性高血压患者体内抗氧化修饰低密度脂蛋白自身抗体的存在:体内低密度脂蛋白氧化增强的生化特征。
J Hypertens. 1995 Jan;13(1):129-38.
3
Association of serum vitamin levels, LDL susceptibility to oxidation, and autoantibodies against MDA-LDL with carotid atherosclerosis. A case-control study. The ARIC Study Investigators. Atherosclerosis Risk in Communities.血清维生素水平、低密度脂蛋白氧化易感性及抗丙二醛修饰低密度脂蛋白自身抗体与颈动脉粥样硬化的关联。一项病例对照研究。社区动脉粥样硬化风险研究(ARIC研究)调查人员。
Arterioscler Thromb Vasc Biol. 1997 Jun;17(6):1171-7. doi: 10.1161/01.atv.17.6.1171.
4
Immunoglobulin M type of autoantibodies to oxidized low-density lipoprotein has an inverse relation to carotid artery atherosclerosis.氧化型低密度脂蛋白免疫球蛋白M型自身抗体与颈动脉粥样硬化呈负相关。
Circulation. 2003 Oct 28;108(17):2107-12. doi: 10.1161/01.CIR.0000092891.55157.A7. Epub 2003 Oct 6.
5
Autoantibodies against oxidized LDL do not predict atherosclerotic vascular disease in non-insulin-dependent diabetes mellitus.抗氧化型低密度脂蛋白自身抗体不能预测非胰岛素依赖型糖尿病患者的动脉粥样硬化性血管疾病。
Arterioscler Thromb Vasc Biol. 1996 Oct;16(10):1236-42. doi: 10.1161/01.atv.16.10.1236.
6
Immunization of LDL receptor-deficient mice with homologous malondialdehyde-modified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes.用同源丙二醛修饰的和天然低密度脂蛋白对低密度脂蛋白受体缺陷小鼠进行免疫接种,通过诱导针对氧化新表位的高滴度抗体以外的机制降低动脉粥样硬化的进展。
Arterioscler Thromb Vasc Biol. 1998 Dec;18(12):1972-82. doi: 10.1161/01.atv.18.12.1972.
7
Autoantibodies against oxidatively modified low-density lipoproteins in NIDDM.非胰岛素依赖型糖尿病患者中针对氧化修饰低密度脂蛋白的自身抗体
Diabetes. 1995 Jan;44(1):60-6. doi: 10.2337/diab.44.1.60.
8
Carotid intima-media thickening and in vivo LDL oxidation in patients with essential hypertension.原发性高血压患者的颈动脉内膜中层增厚及体内低密度脂蛋白氧化
J Hum Hypertens. 1996 Sep;10(9):577-82.
9
LDL oxidation in patients with severe carotid atherosclerosis. A study of in vitro and in vivo oxidation markers.重度颈动脉粥样硬化患者的低密度脂蛋白氧化。一项关于体外和体内氧化标志物的研究。
Arterioscler Thromb. 1994 Dec;14(12):1892-9. doi: 10.1161/01.atv.14.12.1892.
10
Changes of autoantibodies against oxidatively modified low density lipoproteins during long-term LDL-apheresis.长期低密度脂蛋白去除术期间抗氧化修饰低密度脂蛋白自身抗体的变化
Diabetes Nutr Metab. 1999 Dec;12(6):413-7.

引用本文的文献

1
The Role of Lipids in Atherosclerosis: Focus on Molecular Biology Mechanisms and Therapeutic Approaches.脂质在动脉粥样硬化中的作用:聚焦分子生物学机制与治疗方法。
Curr Med Chem. 2025;32(15):3044-3068. doi: 10.2174/0109298673348217241119063941.
2
Overview of Clinical Relevance of Antibodies Against Oxidized Low-Density Lipoprotein (oLAb) Within Three Decades by ELISA Technology.酶联免疫吸附测定技术在三个十年内对氧化型低密度脂蛋白抗体(oLAb)临床相关性的概述
Antioxidants (Basel). 2024 Dec 19;13(12):1560. doi: 10.3390/antiox13121560.
3
Clones reactive to apoptotic cells and specific chemical adducts are prevalent among human thymic B cells.
在人类胸腺 B 细胞中,普遍存在对凋亡细胞和特定化学加合物有反应的克隆。
Front Immunol. 2024 Oct 21;15:1462126. doi: 10.3389/fimmu.2024.1462126. eCollection 2024.
4
The functions of apolipoproteins and lipoproteins in health and disease.载脂蛋白和脂蛋白在健康和疾病中的功能。
Mol Biomed. 2024 Oct 28;5(1):53. doi: 10.1186/s43556-024-00218-7.
5
The Role of Antioxidants in the Therapy of Cardiovascular Diseases-A Literature Review.抗氧化剂在心血管疾病治疗中的作用——文献综述。
Nutrients. 2024 Aug 6;16(16):2587. doi: 10.3390/nu16162587.
6
Atherosclerosis antigens as targets for immunotherapy.动脉粥样硬化抗原作为免疫治疗的靶点。
Nat Cardiovasc Res. 2023 Dec;2(12):1129-1147. doi: 10.1038/s44161-023-00376-x. Epub 2023 Dec 11.
7
B cells and atherosclerosis: A HIV perspective.B 细胞与动脉粥样硬化:HIV 的视角。
J Cell Physiol. 2024 Jun;239(6):e31270. doi: 10.1002/jcp.31270. Epub 2024 Apr 23.
8
Unveiling Complexity: A Case Report of Catastrophic Antiphospholipid Syndrome With Coronary Occlusion and a Concomitant Patent Foramen Ovale Shunt.揭示复杂性:一例伴有冠状动脉闭塞和卵圆孔未闭分流的灾难性抗磷脂综合征病例报告。
Cureus. 2023 Nov 7;15(11):e48456. doi: 10.7759/cureus.48456. eCollection 2023 Nov.
9
Antibodies against malondialdehyde among 60-year-olds: prediction of cardiovascular disease.60 岁人群中丙二醛抗体:心血管疾病的预测。
Sci Rep. 2023 Sep 11;13(1):15011. doi: 10.1038/s41598-023-42264-1.
10
Antibodies against Phosphorylcholine-Implications for Chronic Inflammatory Diseases.抗磷酸胆碱抗体——对慢性炎症性疾病的影响
Metabolites. 2023 Jun 1;13(6):720. doi: 10.3390/metabo13060720.